Author

Jill Paroly

Institution: University of California, Los Angeles

Observed institution: University of California, Los Angeles

OpenAlex ID: A5086965749

A multicenter open-label phase II study of the efficacy and safety of palbociclib a cyclin-dependent kinases 4 and 6 inhibitor in patients with recurrent ovarian cancer.

2016 · Gottfried E. Konecny, Andrea Elisabeth Wahner Hendrickson, et al. · Journal of Clinical Oncology · 28

Works count: 1

Citation count: 28

H-index: 1

I10-index: 1